CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Malakoplakia: evidence for an acquired disease secondary to immunosuppression.

Transplantation 1981 Februrary
A 44-year-old man was maintained on prednisone and azathioprine after renal transplantation. One and a half years after transplantation, he developed multiple perianal Escherichia coli abscesses. These became chronic and resisted antibiotic therapy. Histologically, the lesions were typical of malakoplakia. Peripheral blood neutrophils and monocytes had impaired killing of Staphylococcus aureus and E. coli in vitro. No abnormality of hexose monophosphate pathway activity, tetrazolium dye reduction, lysosomal degranulation, or cyclic nucleotides could be demonstrated in either neutrophils or monocytes. Cholinergic agonists in vitro and in vivo did not improve bacterial killing by these cells. The infection resolved rapidly and bacterial killing returned to normal when the dose of azathioprine was reduced. Our findings, when considered with previous reports, suggest that there are different causes of malakoplakia and malakoplakia may be more common than previously thought. The etiology of malakoplakia should be identified for each patient if appropriate treatment is to be given.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app